Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 USD | -8.54% | -14.29% | +165.49% |
May. 09 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
May. 09 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
Financials (USD)
Sales 2024 * | 74.17M | Sales 2025 * | 66.42M | Capitalization | 301M |
---|---|---|---|---|---|
Net income 2024 * | -156M | Net income 2025 * | -175M | EV / Sales 2024 * | 2.87 x |
Net cash position 2024 * | 88.37M | Net cash position 2025 * | 216M | EV / Sales 2025 * | 1.28 x |
P/E ratio 2024 * |
-1.85
x | P/E ratio 2025 * |
-2.16
x | Employees | 137 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.64% |
Latest transcript on Nektar Therapeutics
1 day | -8.54% | ||
1 week | -14.29% | ||
Current month | +2.74% | ||
1 month | +13.64% | ||
3 months | +100.00% | ||
6 months | +233.33% | ||
Current year | +165.49% |
Managers | Title | Age | Since |
---|---|---|---|
Howard Robin
CEO | Chief Executive Officer | 71 | 06-12-31 |
Robert Chess
CHM | Chairman | 66 | 91-11-30 |
Sandra Gardiner
DFI | Director of Finance/CFO | 58 | 23-04-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
R. Greer
BRD | Director/Board Member | 65 | 09-12-31 |
Roy Whitfield
BRD | Director/Board Member | 70 | 00-07-31 |
Robert Chess
CHM | Chairman | 66 | 91-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.32% | 14 M€ | -4.84% | ||
0.06% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 1.5 | -8.54% | 2,734,305 |
24-05-24 | 1.64 | -1.20% | 1,135,048 |
24-05-23 | 1.66 | -5.14% | 1,314,430 |
24-05-22 | 1.75 | +2.94% | 1,816,684 |
24-05-21 | 1.7 | -2.86% | 1,443,557 |
Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+165.49% | 301M | |
+38.59% | 727B | |
-7.89% | 354B | |
+15.66% | 328B | |
+0.24% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+4.23% | 164B | |
-1.70% | 164B |
- Stock Market
- Equities
- NKTR Stock